Clinical trial
Role of Sclerostin in Mastocytosis Bone Disease
NCT06440148 is registered in ClinicalTrials.gov with Medical University of Lublin as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Role of Sclerostin in Mastocytosis Bone Disease
- Lead sponsor
- Medical University of Lublin
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- September 1, 2019
- Completion date
- December 31, 2026
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
bones, mastocytosis